Please use symbol entry at top right of page to search

In-vitro Diagnostics Instruments Market Size to Grow by USD 23 Billion| Evolving Opportunities with Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc. | 17,000+ Technavio Reports

NEW YORK, April 11, 2022 /PRNewswire/ -- The In-vitro diagnostics instruments market analysis report has been added to Technavio's catalog. The report identifies the market potential growth to reach USD 23 billion from 2020 to 2025. The report also predicts the market to witness an accelerating growth momentum at a CAGR of 7.95% during the forecast period. This growth can be attributed to growing geriatric population. However, strained laboratory budgets and lowering reimbursements affecting instrument sales can hamper the growth of the market during the next few years.

Technavio has announced its latest market research report titled In-vitro Diagnostics Instruments Market by Product, End user, and Geography - Forecast and Analysis 2021-2025

 

Grab this latest in-vitro diagnostics instruments market report sample from Technavio Here!

Read the 120-page report with TOC on "In-vitro Diagnostics Instruments Market Analysis Report by Product (Immunochemistry, Clinical microbiology, Molecular diagnostics, and Others), End-user (Hospitals and diagnostic laboratories, Academic and research institutes, and Home care), and Geography (North America, Europe, Asia, and ROW), and the Segment Forecasts,2021-2025". Gain competitive intelligence about market leaders. Track key industry opportunities, trends, and threats. Information on marketing, brand, strategy and market development, sales and supply functions. https://www.technavio.com/report/report/in-vitro-diagnostics-instruments-market-industry-analysis

Key Market Dynamics

The in-vitro diagnostics instruments market is attributed to growing geriatric population and demand for personalized medicine. The prevalence of diseases, such as lung disease, cancer, and stroke, is high among the aging population. There is a direct relationship between aging and the susceptibility to infections, as the immune system deteriorates with age. The rise in the aging population has also resulted in increased expenditure on healthcare for health check-ups, disease diagnosis, and treatment. The elderly population requires diagnostic testing regularly due to their low immunity and metabolism. These factors have increased the demand for in-vitro diagnostics instruments, as these instruments assist in disease diagnosis. 

However, reimbursement policies for diagnostic testing are not constant across various geographies, and they are moving in a downward trend. Hospitals and diagnostic laboratories that are the primary end-users are forced to reduce their expenditure on in-vitro diagnostics instruments to have either break even or profitable revenue. The US has similar situations for in-vitro diagnostics instruments, and a reduction of reimbursement by Medicare may limit the demand for certain diagnostic testing across all segments. This has, in turn, affected the sales of new instruments for in-vitro diagnostics testing. 

Find report sample PDF here to get a detailed market share analysis of market participants

Top In-vitro Diagnostics Instruments Companies:

  • Abbott Laboratories: The company offers in-vitro diagnostics instruments namely Sapphire, Ruby, Emerald 22AL, and others.
  • Becton Dickinson and Co.: The company offers in-vitro diagnostics instruments for mycobacteria testing, and identification and susceptibility systems.
  • Bio Rad Laboratories Inc.: The company offers in-vitro diagnostics instruments to screen of microbial presence, grow and identify organisms, and test for antibiotic susceptibility.
  • bioMerieux SA: The company offers in-vitro diagnostics instruments for laboratory optimization.
  • Danaher Corp. : The company offers in-vitro diagnostics instruments namely DxH 900, DxH 900 connected workcell, DxH sildemaker stainer, DxH 690T, and Others.
  • F. Hoffmann-La Roche Ltd.: The company offers in-vitro diagnostics instruments for patient self testing, care testing, and next generation sequencing
  • HORIBA Ltd.: The company offers in-vitro diagnostics instruments such as blood analysers, middleware/work ststion, tracking system and others.
  • Siemens AG: The company offers in-vitro diagnostics instruments integrated with artificial intelligence and deep learning technology to reduce the failure rate of automated in vitro diagnostics.
  • Sysmex Corp.: The company offers in-vitro diagnostics instruments to detect medical indications in physiology, pathology, and and human homeostasis.
  • Thermo Fisher Scientific Inc.: The company offers in-vitro diagnostics instruments namely Phadia, Endura MD, and Indiko.

Speak to our Analyst for customized report on each vendor

In-vitro Diagnostics Instruments Market Product Outlook (Revenue, USD bn, 2020-2025)

  • Immunochemistry - size and forecast 2020-2025
  • Clinical microbiology - size and forecast 2020-2025
  • Molecular diagnostics - size and forecast 2020-2025
  • Others - size and forecast 2020-2025

The immunochemistry product segment held the largest market share in 2020. The segment will continue to account for the largest share throughout the forecast period. This segment is the highly automated segment of clinical laboratories and represents the greatest test volume compared with the other types of testing. 

In-vitro Diagnostics Instruments Market Geography Outlook (Revenue, USD bn, 2020-2025)

  • North America - size and forecast 2020-2025
  • Europe - size and forecast 2020-2025
  • Asia - size and forecast 2020-2025
  • ROW - size and forecast 2020-2025

35% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for in-vitro diagnostics instruments in North America. The growing aging population and the high prevalence of chronic and infectious diseases will fuel the in-vitro diagnostics instruments market growth in North America over the forecast period. 

In-vitro Diagnostics Instruments Market End-user Outlook (Revenue, USD bn, 2020-2025)

  • Hospitals and diagnostic laboratories - size and forecast 2020-2025
  • Academic and research institutes - size and forecast 2020-2025
  • Home care - size and forecast 2020-2025

Grab an exclusive free sample report on the contribution of each segment

Related Reports:

In-Vitro Toxicity Testing Market by End-user and Geography - Forecast and Analysis 2022-2026 

In-vitro Diagnostics Market by Technology and Geography - Forecast and Analysis 2021-2025 

In-vitro Diagnostics Instruments Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 7.95%

Market growth 2021-2025

$ 23.00 billion

Market structure

Fragmented

YoY growth (%)

6.23

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 35%

Key consumer countries

US, China, Germany, Canada, and UK

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., HORIBA Ltd., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Content

1. Executive Summary                        

2. In-vitro Diagnostics Instruments Market Landscape                          

              2.1 Market ecosystem            

                             Exhibit 01: Parent market

              2.2: Market Characteristics    

              2.2 Value chain analysis         

                             Exhibit 03: Value chain analysis: Healthcare equipment market

                             2.2.1 Research and development

                             2.2.2 Inputs

                             2.2.3 Operations

                             2.2.4 Distribution

                             2.2.5 Marketing and sales

                             2.2.6 Post-sales and services

                             2.2.7 Industry innovations

3. In-vitro Diagnostics Instruments Market Sizing                     

              3.1 Market definition

                             Exhibit 04: Offerings of vendors included in the market definition

              3.2 Market segment analysis 

                             Exhibit 05: Market segments

              3.3 Market size 2020 

              3.4 Market outlook: Forecast for 2020 - 2025 

                             3.4.1 Estimating growth rates for emerging and high-growth markets

                             3.4.2 Estimating growth rates for mature markets

                             Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)

                             Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

4. Five Forces Analysis                        

              4.1 Five Forces Summary       

                             Exhibit 08: Five forces analysis 2020 & 2025

              4.2 Bargaining power of buyers          

              4.3 Bargaining power of suppliers      

              4.4 Threat of new entrants    

              4.5 Threat of substitutes        

              4.6 Threat of rivalry  

              4.7 Market condition

                             Exhibit 14: Market condition - Five forces 2020

5. In-vitro Diagnostics Instruments Market Segmentation by Product             

              5.1 Market segments

                             The segments covered in this chapter are:

Immunochemistry
Clinical microbiology
Molecular diagnostics
Others

                             Exhibit 15: Product - Market share 2020-2025 (%)

              5.2 Comparison by Product    

                             Exhibit 16: Comparison by Product

              5.3 Immunochemistry - Market size and forecast 2020-2025   

                             Exhibit 17: Immunochemistry - Market size and forecast 2020-2025 ($ million)

                             Exhibit 18: Immunochemistry - Year-over-year growth 2020-2025 (%)

              5.4 Clinical microbiology - Market size and forecast 2020-2025             

                             Exhibit 19: Clinical microbiology - Market size and forecast 2020-2025 ($ million)

                             Exhibit 20: Clinical microbiology - Year-over-year growth 2020-2025 (%)

              5.5 Molecular diagnostics - Market size and forecast 2020-2025             

                             Exhibit 21: Molecular Diagnostics - Market size and forecast 2020-2025 ($ million)

                             Exhibit 22: Molecular diagnostics - Year-over-year growth 2020-2025 (%)

              5.6 Others - Market size and forecast 2020-2025         

                             Exhibit 23: Others - Market size and forecast 2020-2025 ($ million)

                             Exhibit 24: Others - Year-over-year growth 2020-2025 (%)

              5.7 Market opportunity by Product    

                             Exhibit 25: Market opportunity by Product

6. In-vitro Diagnostics Instruments Market Segmentation by End-user                          

              6.1 Market segments

                             Exhibit 26: End-user - Market share 2020-2025 (%)

              6.2 Comparison by End-user 

                             Exhibit 27: Comparison by End-user

              6.3 Hospitals and diagnostic laboratories - Market size and forecast 2020-2025        

                             Exhibit 28: Hospitals and diagnostic laboratories - Market size and forecast 2020-2025 ($ million)

                             Exhibit 29: Hospitals and diagnostic laboratories - Year-over-year growth 2020-2025 (%)

              6.4 Academic and research institutes - Market size and forecast 2020-2025         

                             Exhibit 30: Academic and research institutes - Market size and forecast 2020-2025 ($ million)

                             Exhibit 31: Academic and research institutes - Year-over-year growth 2020-2025 (%)

              6.5 Home care - Market size and forecast 2020-2025  

                             Exhibit 32: Home care - Market size and forecast 2020-2025 ($ million)

                             Exhibit 33: Home care - Year-over-year growth 2020-2025 (%)

              6.6 Market opportunity by End-user  

                             Exhibit 34: Market opportunity by End-user

7. Customer landscape                       

                             Exhibit 35: Customer landscape

8. Geographic Landscape                   

              8.1 Geographic segmentation

                             Exhibit 36: Market share by geography 2020-2025 (%)

              8.2 Geographic comparison  

                             Exhibit 37: Geographic comparison

              8.3 North America - Market size and forecast 2020-2025          

                             Exhibit 38: North America - Market size and forecast 2020-2025 ($ million

                             Exhibit 39: North America - Year-over-year growth 2020-2025 (%)

              8.4 Europe - Market size and forecast 2020-2025         

                             Exhibit 40: Europe - Market size and forecast 2020-2025 ($ million)

                             Exhibit 41: Europe - Year-over-year growth 2020-2025 (%)

              8.5 Asia - Market size and forecast 2020-2025

                             Exhibit 42: Asia - Market size and forecast 2020-2025 ($ million)

                             Exhibit 43: Asia - Year-over-year growth 2020-2025 (%)

              8.6 ROW - Market size and forecast 2020-2025            

                             Exhibit 44: ROW - Market size and forecast 2020-2025 ($ million)

                             Exhibit 45: ROW - Year-over-year growth 2020-2025 (%)

              8.7 Key leading countries       

                             Exhibit 46: Key leading countries

              8.8 Market opportunity by geography

                             Exhibit 47: Market opportunity by geography

9. Drivers, Challenges, and Trends                 

              9.1 Market drivers     

                             9.1.1 Growing geriatric population

                             9.1.2 Demand for personalized medicine

                             9.1.3 Product launches

              9.2 Market challenges             

                             9.2.1 Strained laboratory budgets and lowering reimbursements affecting instrument sales

                             9.2.2 Limited sustainability of smaller vendors

                             9.2.3 Reduction in profits of manufacturers due to US medical device tax policies

                             9.2.4 Limitations of closed systems in in-vitro diagnostics testing

                             Exhibit 48: Impact of drivers and challenges

              9.3 Market trends     

                             9.3.1 Potential opportunities for POL

                             9.3.2 Leasing of in-vitro diagnostics instruments

                             9.3.3 Growing importance for promotional activities

                             9.3.4 Technological advances in in-vitro diagnostics

10. Vendor Landscape                        

              10.1  Competitive scenario    

              10.2  Vendor landscape          

                             Exhibit 40: Vendor Landscape

              10.3  Landscape disruption    

                             Exhibit 41: Landscape disruption

              10.4  Industry risks    

                             Exhibit 42: Industry risks

11.  Vendor Analysis                           

              11.1  Vendors covered            

                             Exhibit 43: Vendors covered

              11.2 Market positioning of vendors  

                             Exhibit 53: Market positioning of vendors

              11.3 Abbott Laboratories       

                             Exhibit 54: Abbott Laboratories - Overview

                             Exhibit 55: Abbott Laboratories - Business segments

                             Exhibit 56: Abbott Laboratories - Key offerings

                             Exhibit 57: Abbott Laboratories - Segment focus

              11.4 Becton Dickinson and Co.            

                             Exhibit 58: Becton Dickinson and Co. - Overview

                             Exhibit 59: Becton Dickinson and Co. - Business segments

                             Exhibit 60: Becton Dickinson and Co. - Key News

                             Exhibit 61: Becton Dickinson and Co. - Key offerings

                             Exhibit 62: Becton Dickinson and Co. - Segment focus

              11.5 Bio Rad Laboratories Inc.             

                             Exhibit 63: Bio Rad Laboratories Inc. - Overview

                             Exhibit 64: Bio Rad Laboratories Inc. - Business segments

                             Exhibit 65: Bio Rad Laboratories Inc. - Key News

                             Exhibit 66: Bio Rad Laboratories Inc. - Key offerings

                             Exhibit 67: Bio Rad Laboratories Inc. - Segment focus

              11.6 bioMerieux SA   

                             Exhibit 68: bioMerieux SA - Overview

                             Exhibit 69: bioMerieux SA - Business segments

                             Exhibit 70: bioMerieux SA - Key offerings

                             Exhibit 71: bioMerieux SA - Segment focus

              11.7 Danaher Corp.   

                             Exhibit 72: Danaher Corp. - Overview

                             Exhibit 73: Danaher Corp. - Business segments

                             Exhibit 74: Danaher Corp. - Key News

                             Exhibit 75: Danaher Corp. - Key offerings

                             Exhibit 76: Danaher Corp. - Segment focus

              11.8 F. Hoffmann-La Roche Ltd.          

                             Exhibit 77: F. Hoffmann-La Roche Ltd. - Overview

                             Exhibit 78: F. Hoffmann-La Roche Ltd. - Business segments

                             Exhibit 79: F. Hoffmann-La Roche Ltd. - Key News

                             Exhibit 80: F. Hoffmann-La Roche Ltd. - Key offerings

                             Exhibit 81: F. Hoffmann-La Roche Ltd. - Segment focus

              11.9 HORIBA Ltd.       

                             Exhibit 82: HORIBA Ltd. - Overview

                             Exhibit 83: HORIBA Ltd. - Business segments

                             Exhibit 84: HORIBA Ltd. - Key offerings

                             Exhibit 85: HORIBA Ltd. - Segment focus

              11.10 Siemens AG     

                             Exhibit 86: Siemens AG - Overview

                             Exhibit 87: Siemens AG - Business segments

                             Exhibit 88: Siemens AG - Key News

                             Exhibit 89: Siemens AG - Key offerings

                             Exhibit 90: Siemens AG - Segment focus

              11.11 Sysmex Corp.  

                             Exhibit 91: Sysmex Corp. - Overview

                             Exhibit 92: Sysmex Corp. - Business segments

                             Exhibit 93: Sysmex Corp. - Key offerings

                             Exhibit 94: Sysmex Corp. - Segment focus

              11.12 Thermo Fisher Scientific Inc.     

                             Exhibit 95: Thermo Fisher Scientific Inc. - Overview

                             Exhibit 96: Thermo Fisher Scientific Inc. - Business segments

                             Exhibit 97: Thermo Fisher Scientific Inc. - Key News

                             Exhibit 98: Thermo Fisher Scientific Inc. - Key offerings

                             Exhibit 99: Thermo Fisher Scientific Inc. - Segment focus

12. Appendix                          

              12.1 Scope of the report        

                             12.1.1 Market definition

                             12.1.2 Objectives

                             12.1.3 Notes and caveats

              12.2 Currency conversion rates for US$           

                             Exhibit 82: Currency conversion rates for US$

              12.3 Research Methodology  

                             Exhibit 83: Research Methodology

                             Exhibit 84: Validation techniques employed for market sizing

                             Exhibit 85: Information sources

              12.4 List of abbreviations       

About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

SOURCE Technavio

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.